Brief: Achilles Therapeutics reports Q2 results
09/08/2022 12:37
Aug 9 (Reuters) - Achilles Therapeutics PLC 698y.F :
* ACHILLES THERAPEUTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* Q2 LOSS PER SHARE $0.44
* QTRLY LOSS PER SHARE $0.44
Source text for Eikon: ID:nGNX3tnS4S
Further company coverage: 698y.F
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement